What is Tango Therapeutics's net income?

Tango Therapeutics (TNGX) reported net income of -$45.51M in Q1 2026.

How has Tango Therapeutics's net income changed year-over-year?

Tango Therapeutics's net income decreased by 14.1% year-over-year, from -$39.88M to -$45.51M.

What is the long-term trend for Tango Therapeutics's net income?

Over 4 years (2021 to 2025), Tango Therapeutics's net income has grown at a 14.9% compound annual growth rate (CAGR), from -$58.24M to -$101.59M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Tango Therapeutics TNGX Net Income

Net Income at other companies

Bristol-Myers SquibbBMY

$2.68B+8.8%

AmgenAMGN

$1.82B+5.1%

Gilead SciencesGILD

$2.02B+53.7%

ExelixisEXEL

$210.47M+31.9%

Cogent Biosciences, Inc.COGT

-$97.35M-35.2%

CG OncologyCGON

-$60.2M-74.7%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's net income?: Tango Therapeutics (TNGX) reported net income of -$45.51M in Q1 2026.
How has Tango Therapeutics's net income changed year-over-year?: Tango Therapeutics's net income decreased by 14.1% year-over-year, from -$39.88M to -$45.51M.
What is the long-term trend for Tango Therapeutics's net income?: Over 4 years (2021 to 2025), Tango Therapeutics's net income has grown at a 14.9% compound annual growth rate (CAGR), from -$58.24M to -$101.59M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.